Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$220.06 USD
+2.89 (1.33%)
Updated May 17, 2024 04:00 PM ET
After-Market: $220.48 +0.42 (0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -7.55 |
EPS Last Quarter | -7.38 |
Last EPS Surprise | -21.78% |
ABR | 1.47 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -27.62 |
Next Year | -17.59 |
EPS (TTM) | -23.09 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.79M | 22.31M | 77.62M | 347.11M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 5.40M | 28.60M | 92.36M | 509.00M |
Low Estimate | 0.90M | 16.00M | 61.00M | 201.78M |
Year ago Sales | 0.00M | 0.00M | NA | 77.62M |
Year over Year Growth Est. | NA | NA | NA | 347.21% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -7.55 | -6.96 | -27.62 | -17.59 |
# of Estimates | 9 | 7 | 9 | 9 |
Most Recent Consensus | -8.36 | -7.63 | -28.90 | -24.37 |
High Estimate | -6.52 | -6.37 | -25.64 | -6.54 |
Low Estimate | -9.37 | -7.74 | -30.66 | -24.37 |
Year ago EPS | -4.69 | -5.34 | -19.99 | -27.62 |
Year over Year Growth Est. | -60.98% | -30.34% | -38.17% | 36.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 6 | 6 | 8 | 7 |
Down Last 60 Days | 6 | 6 | 8 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -7.55 | -6.96 | -27.62 | -17.59 |
7 Days Ago | -7.55 | -6.96 | -27.62 | -17.59 |
30 Days Ago | -5.97 | -5.35 | -21.48 | -13.50 |
60 Days Ago | -5.97 | -5.35 | -21.48 | -13.50 |
90 Days Ago | -4.44 | -4.48 | -15.33 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -7.55 | -6.96 | -27.62 | -17.59 |
Zacks Consensus Estimate | -7.55 | -6.96 | -27.62 | -17.59 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -7.38 | -5.68 | -5.34 | -4.69 | NA |
Estimate | -6.06 | -5.32 | -4.78 | -4.47 | NA |
Difference | -1.32 | -0.36 | -0.56 | -0.22 | -0.62 |
Surprise | -21.78% | -6.77% | -11.72% | -4.92% | -11.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more